Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Hypertension. 2016 Nov 28;69(1):79–86. doi: 10.1161/HYPERTENSIONAHA.116.08278

Figure 4.

Figure 4

Cav1 silencing attenuates AngII-induced VSMC remodeling in vitro. VSMCs were pretreated with adenovirus encoding Cav1 silencing siRNA or control non-silencing siRNA for 48 hours and were stimulated with AngII (100 nmol/L) for 48 hours. Extracellular collagen accumulation, total cell protein and cell volume were evaluated. Means ± SEM (n=4). *p<0.05 compared with basal. †p<0.05 compared with control AngII stimulation.